Evolutionary History and Attenuation of Myxoma Virus on Two Continents

PLoS Pathogens

Volumn 8, Issue 10, 2012, Pages

  Kerr, Peter J ^a   Ghedin, Elodie ^b   DePasse, Jay V ^b   Fitch, Adam ^b   Cattadori, Isabella M ^c   Hudson, Peter J ^c   Tscharke, David C ^d   Read, Andrew F ^c,e   Holmes, Edward C ^c,e  

^a CSIRO   (Australia)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED DNA; NUCLEOTIDE;

AMINO ACID SUBSTITUTION; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DNA VIRUS; EUROPE; EVOLUTION; GENE DELETION; GENE FUNCTION; GENE INSERTION; MUTATION RATE; MYXOMA VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; VIRUS ATTENUATION; VIRUS GENOME; VIRUS MUTATION; VIRUS VIRULENCE;

ANIMALS; AUSTRALIA; BASE SEQUENCE; BIOLOGICAL EVOLUTION; DNA, VIRAL; EUROPE; EVOLUTION, MOLECULAR; GENOME, VIRAL; MOLECULAR SEQUENCE DATA; MUTATION RATE; MYXOMA VIRUS; MYXOMATOSIS, INFECTIOUS; PHYLOGENY; RABBITS; SEQUENCE ANALYSIS, DNA;

DNA VIRUSES; MYXOMA VIRUS; ORYCTOLAGUS CUNICULUS;

EID: 84868090378     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002950     Document Type: Article

References (50)

1. Fenner F, Ratcliffe FN (1965) Myxomatosis. Cambridge: Cambridge University Press.
2. Fenner F, Day MF, Woodroofe GM, (1956) Epidemiological consequences of the mechanical transmission of myxomatosis by mosquitoes. J Hyg (Camb) 54: 284-303.
3. Fenner F, Marshall ID, (1957) A comparison of the virulence for European rabbits (Oryctolagus cuniculus) of strains of myxoma virus recovered in the field in Australia, Europe and America. J Hyg (Camb) 55: 149-191.
4. Day MF, Fenner F, Woodroofe GM, McIntyre GA, (1956) Further studies on the mechanism of mosquito transmission of myxomatosis in the European rabbit. J Hyg (Camb) 54: 258-283.
5. Fenner F, (1983) Biological control as exemplified by smallpox eradication and myxomatosis. Proc Royal Soc Lond B 218: 259-285.
6. Marshall ID, Douglas GW, (1961) Studies in the epidemiology of infectious myxomatosis of rabbits. VIII. Further observations on changes in the innate resistance of Australian wild rabbits exposed to myxomatosis. J Hyg (Camb) 59: 117-122.
7. Marshall ID, Fenner F, (1959) Studies in the epidemiology of infectious myxomatosis of rabbits. V. Changes in the innate resistance of wild rabbits between 1951 and 1959. J Hyg (Camb) 56: 288-302.
8. Best SM, Kerr PJ, (2000) Coevolution of host and virus: the pathogenesis of virulent and attenuated strains of myxoma virus in resistant and susceptible European rabbits. Virology 267: 36-48.
9. Kerr PJ, McFadden G, (2002) The immune response to myxoma virus. Viral Immunol 15: 229-246.
10. Anderson RM, May RM, (1982) Coevolution of hosts and parasites. Parasitol 85: 411-426.
11. Bull JJ, (1994) Virulence. Evolution 48: 1423-1437.
12. Mackinnon MJ, Gandon S, Read AF, (2008) Virulence evolution in response to vaccination: The case of malaria. Vaccine 26: C42-C52.
13. Read AF, (1994) The evolution of virulence. Trends Microbiol 2: 73-76.
14. Dwyer G, Levin SA, Buttel L, (1990) A simulation model of the population dynamics and evolution of myxomatosis. Ecol Monog 60: 423-447.
15. Boots M, Hudson PJ, Sasaki A, (2004) Large shifts in pathogen virulence relate to host population structure. Science 303: 842-845.
16. Cameron C, Hota-Mitchell S, Chen L, Barrett J, Cao J-X, et al. (1999) The complete DNA sequence of myxoma virus. Virology 264: 298-318.
17. Stanford MM, Werden SJ, McFadden G, (2007) Myxoma virus in the European rabbit: interactions between the virus and its susceptible host. Vet Res 38: 299-318.
18. Morales M, Ramirez MA, Cano MJ, Parraga M, Castilla J, et al. (2009) Genome comparison of a nonpathogenic myxoma virus field strain with its ancestor, the virulent Lausanne strain. J Virol 83: 2397-2403.
19. Drummond AJ, Rambaut A, (2007) BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7: 214-221.
20. Kerr PJ, Jackson RJ, Robinson AJ, Swan J, Silvers L, et al. (1999) Infertility in female rabbits (Oryctolagus cuniculus) alloimmunized with the rabbit zona pellucida protein ZPB either as a purified recombinant protein or expressed by recombinant myxoma virus. Biol Reprod 61: 606-613.
21. Douglas GW, (1962) The Glenfield strain of myxoma virus. Its use in Victoria. J Agri (Victoria) 60: 511-515.
22. Saint KM, French N, Kerr PJ, (2001) Genetic variation in Australian isolates of myxoma virus: an evolutionary and epidemiological study. Arch Virol 146: 1105-1123.
23. Werden SJ, McFadden G, (2008) The role of cell signaling in poxvirus tropism: the case of the M-T5 host range protein of myxoma virus. Biochim Biophys Acta 1784: 228-237.
24. Mossman K, Fong Lee S, Barry M, Boshkov L, McFadden G, (1996) Disruption of M-T5, a novel myxoma virus gene member of the poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits. J Virol 70: 4394-4410.
25. Collin N, Guérin J-L, Drexler I, Blanié S, Gelfi J, et al. (2005) The poxviral scrapin MV-LAP requires a myxoma viral infection context to efficiently downregulate MHC-I molecules. Virology 343: 171-178.
26. Guérin J-L, Gelfi J, Bouillier S, Delverdier M, Bellanger F-A, et al. (2002) Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class 1 and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins. J Virol 76: 2912-2923.
27. Bartee E, McCormack A, Früh H, (2006) Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog 2: E107.
28. Mansouri M, Bartee E, Gouveia K, Hovey Nerenberg BT, et al. (2003) The PHD/LAP-domain protein M153R of myxoma virus is a ubiquitin ligase that induces the rapid internalization and lysosomal destruction of CD4. J Virol 77: 1427-1440.
29. Blanié S, Gelfi J, Bertagnoli S, Camus-Bouclainville C, (2010) MNF, an ankyrin repeat protein of myxoma virus, is part of a native cellular SCF complex during viral infection. Virol J 7: 56.
30. Camus-Bouclainville C, Fiette L, Bouchiha S, Pignolet B, Counor D, et al. (2004) A virulence factor of myxoma virus colocalizes with NF-kappaB in the nucleus and interferes with inflammation. J Virol 78: 2510-2516.
31. Duffy S, Shackelton LA, Holmes EC, (2008) Rates of evolutionary change in viruses: Patterns and determinants. Nat Rev Genet 9: 267-276.
32. Firth C, Kitchen A, Shapiro B, Suchard MA, Holmes EC, et al. (2010) Using time-structured data to estimate evolutionary rates of double-stranded DNA viruses. Mol Biol Evol 27: 2038-2051.
33. McGeoch DJ, Gatherer D, (2005) Integrating reptilian herpesviruses into the family Herpesviridae. J Virol 79: 725-731.
34. Sanjuán R, Nebot MR, Chirico N, Mansky LM, Belshaw R, (2010) Viral mutation rates. J Virol 84: 9733-9748.
35. Kerr PJ, Merchant JC, Silvers L, Hood G, Robinson AJ, (2003) Monitoring the spread of myxoma virus in rabbit populations in the southern tablelands of New South Wales, Australia. II. Selection of a virus strain that was transmissible and could be monitored by polymerase chain reaction. Epidemiol Infect 130: 123-133.
36. Kerr PJ, Perkins HD, Inglis B, Stagg R, McLaughlin E, et al. (2004) Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis. Virology 324: 117-128.
37. Mead-Briggs AR, Vaughan JA, (1975) The differential transmissibility of myxoma virus strains of differing virulence grades by the rabbit flea Spilopsyllus cuniculi (Dale). J Hyg (Camb) 75: 237-247.
38. Kerr PJ, Hone J, Perrin L, French N, Williams CK, (2010) Molecular and serological analysis of the epidemiology of myxoma virus in rabbits. Vet Microbiol 143: 167-178.
39. Brault AC, Huang C Y-H, Langevin SA, Kinney RM, Bowen RA, et al. (2007) A single positively selected West Nile viral mutation confers increased avian virogenesis in American crows. Nat Genet 39: 1162-1166.
40. Baigent SJ, McCauley JW, (2003) Influenza type A in humans, mammals and birds: determinants of virus virulence, host-range and interspecies transmission. Bioessays 25: 657-671.
41. Fenyö EM, Albert J, Asjö B, (1989) Replicative capacity, cytopathic effect and cell tropism of HIV. AIDS 3: S5-12.
42. Connor RI, Ho DD, (1994) Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J Virol 68: 4400-4408.
43. Kimata JT, Kuller L, Anderson DB, Dailey P, Overbaugh J, (1999) Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat Med 5: 535-541.
44. Holmes EC (2009) The Evolution and Emergence of RNA viruses. Oxford: Oxford University Press.
45. Pop M, Phillippy A, Delcher AL, Salzberg SL, (2004) Comparative genome assembly. Briefings Bioinformat 5: 237-248.
46. Martin DP, Lemey P, Lott M, Moulton V, Posada D, et al. (2010) RDP3: a flexible and fast computer program for analyzing recombination. Bioinformatics 26: 2462.
47. Swofford DL (2003) PAUP*. Phylogenetic Analysis Using Parsimony (*and other methods). Version 4. Sunderland, Mass: Sinauer Associates.
48. Moses A, (1911) O virus do myxoma dos coelhos. Mem Inst Osw Cruz 3: 46-53.
49. Russell RJ, Robbins SJ, (1989) Cloning and molecular characterization of the myxoma virus genome. Virology 170: 147-159.
50. Berman D, Kerr PJ, Stagg R. van Leeuwen BH, Gonzalez T, (2006) Should the 40-year-old practice of releasing virulent myxoma virus to control rabbits (Oryctolagus cuniculus) be continued? Wildl Res 33: 549-556.